Omisan Farmaceutici

Name

Omisan Farmaceutici

Legal name

OMISAN S.p.A. a socio unico

Website

https://omisan.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Ophthalmic Goods (3851)

akta.pro primary industry

Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

akta.pro secondary industries

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

Keywords

• Ophthalmic medical devices
• Eye care products
• Contact lens solutions
• Preservative-free formulations
• CDMO manufacturing services

Headquarters

HQ city

Guidonia

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Sterile Medical Device Sales: Development, production and commercialization of sterile medical devices including eye drops, sprays, eyewashes, disposable ophthalmic gauzes, and contact lens solutions. Products are sold to pharmacies, drugstores, opticians and optical stores globally.
2. Private Label Manufacturing: Personalization and private label manufacturing of CE certified products and formulations for pharmacies and retail chains. OMISAN acts as official manufacturer and supplier for leading multinational ophthalmic companies.
3. CDMO Services: Contract Development and Manufacturing Organization services matching highest production standards for pharmaceutical and ophthalmic companies requiring custom manufacturing solutions.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Omisan Farmaceutici develops, produces, and commercializes sterile ophthalmic medical devices (Class 2B) under branded product lines covering eye drops, micro-nebulizer corneal sprays, eyewashes, disposable ophthalmic gauzes, contact lenses, and contact lens care solutions. In parallel, it provides Private Label manufacturing, in-licensing, and CDMO (Contract Development and Manufacturing Organization) services for leading multinational ophthalmic companies.

Product overview

Omisan Farmaceutici is an Italian pharmaceutical company specializing in the development, production, and commercialization of Sterile Medical Devices for eye care and contact lens solutions. The product portfolio comprises multiple product lines: NebuVis (micro-nebulizer sprays for open-eye application), Oftyll (flower extracts-based products), PharmaVis (hyaluronic acid and plant extracts), EasyDay (hyaluronic acid products for women), Sodyal (dry eye hyaluronic acid products), and BioXesin (Aloe vera-based products). Additionally, the Specialists line includes specialized products such as Corneanorm, Elicrisin, Lipovisial, Lutevisial, Siccanorm, Terpidex (Spray, Garze, Schiuma), Visial, Visial X, Neutralid NET, Myodesonorm, Resveravisial, Visialens contact lenses, and Pulilens lens cleanser. The company also offers Private Label and Contract Manufacturing Organization (CDMO) services, with unique portfolio of Class 2B Ophthalmic Medical Devices including eye drops, eye washes, and contact lens care solutions with innovative preservative-free technologies (single-dose, OSD Aptar, 3K Aeropump, Novelia Nemera).

Differentiator

Problem solved

Functional benefit

Brands

• BioXesin: All Aloe vera based products for eye and nasal care
• NebuVis
• Oftyll
• PharmaVis
• EasyDay
• Sodyal
• BioXesin Eye Spray
• BioXesin Eye Drops
• BioXesin Eye Wet Wipes
• Sodyal 24H
• Sodyal LIPOCOMFORT
• Sodyal PROTECT
• Sodyal X
• Sodyal XLipo
• Sodyal PLUS
• Sodyal INTENSIVE
• EasyDay Drops
• EasyDay Multi-Action Spray
• EasyDay Multi
• EasyDay Salina
• Easy Day Lens
• AloVISgel
• AllergoVis
• CalenduVis
• Ocumill
• Ocumill SDU
• UniVis Bio
• ContactVis Extra Comfort Lens
• Allergoftyll
• Calendoftyll
• Oftylla
• Oftyll Clean Drops
• NebuVis Eye Hydration
• NebuVis Irritated Eyes
• CORNEANORM
• ELICRISIN
• LIPOVISIAL
• LUTEVISIAL
• SICCANORM
• TERPIDEX SPRAY
• VISIAL
• VISIAL X
• TERPIDEX GARZE
• NEUTRALID NET
• MYODESONORM
• RESVERAVISIAL
• VISIALENS BIOMIMETICA
• VISIALENS PROFESSIONAL
• TERPIDEX SCHIUMA
• PULILENS

Products and services

• NebuVis Micro-nebulizer corneal sprays for eye hydration and irritation relief, applied with eyes open for uniform distribution over the ocular surface; sold to end consumers via pharmacies, drugstores, and optical stores.
• Oftyll All flower extracts based eye and contact lens care products, including variants for allergic conjunctivitis, irritated eyes, and contact lens comfort; sold to end consumers through pharmacy and optical retail.
• PharmaVis Hyaluronic acid and plant extracts based eye care products for dry, irritated, and sensitive eyes as well as contact lens care, available in multiple formulation variants.
• EasyDay Eye and contact lens care products with hyaluronic acid designed for women, including eye drops, hydrating multi-action sprays, and contact lens maintenance solutions.
• Sodyal Dry eye products based on hyaluronic acid offering lubrication and moisturization, including preservative-free and liposomal variants targeting mild to intensive dry eye symptoms.
• BioXesin All Aloe vera based products for eye and nasal care, including eye sprays with micro-nebulization, Aloe vera gel eye drops, and eye wet wipes for hygiene and hydration.
• Specialists line (Specialist ophthalmic solutions) Specialty sterile ophthalmic products including hypertonic corneal edema solutions, liposomal sprays, eyelid hygiene wipes and foams, food supplements for eye health, and daily/monthly disposable contact lenses for prescription and maintenance use.
• Private Label and in-licensing of CE certified ophthalmic products Personalization, Private Label, and in-licensing of Omisan's own CE certified sterile ophthalmic products and formulations for pharmacies, retail chains, and leading multinational ophthalmic companies.
• CDMO (Contract Development and Manufacturing Organization) services CDMO services for pharmaceutical and ophthalmic companies requiring custom development and manufacturing of sterile ophthalmic medical devices, leveraging Omisan's R&D Department, brand-new production facilities, and proprietary preservative-free and micro-nebulizer technologies.

Quantifiable outcome

• Over 350 million people worldwide suffer from dry eye syndrome, with approximately 15 million in Italy alone

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Leading Multinational Ophthalmic CompaniescoreChannel Partner/ Reseller/ DistributorOMISAN serves as the official manufacturer and supplier for many leading multinationals in the ophthalmic sector. The company offers private label, in-licensing, and CDMO services matching the highest production standards (CE Mark, ISO13485, BRC).

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bausch + Lomb: Global ophthalmic company with a broad portfolio of eye drops, contact lens solutions, and dry-eye treatments directly overlapping OMISAN's consumer eye-care lines such as Sodyal and EasyDay.
• Alcon: World leader in eye care, including over-the-counter eye drops (e.g., Systane), contact lens solutions, and surgical ophthalmics; competes with OMISAN across both consumer and CDMO channels.
• Théa Laboratories: European specialty ophthalmic pharma company focused on preservative-free eye drops and dry-eye products, closely comparable to OMISAN in size, geography, and preservative-free technology positioning.
• SIFI S.p.A. Italian ophthalmic company developing and marketing eye drops, contact lens care, and ocular surface disease treatments; comparable domestic peer with similar size and therapeutic focus.
• Similasan: Swiss natural eye-care brand selling plant- and mineral-based eye drops for dryness, allergies, and irritation; comparable to OMISAN's BioXesin, Oftyll, and PharmaVis natural-extract lines.

Broad incumbents

• Allergan (AbbVie): Major pharmaceutical incumbent with a leading ophthalmic franchise including Refresh Tears and Restasis; competes broadly with OMISAN in preservative-free and dry-eye categories.
• Santen Pharmaceutical: Japanese specialty ophthalmic company with a global prescription and OTC eye-care portfolio, overlapping with OMISAN's hyaluronic-acid and dry-eye offerings across international markets.
• Johnson & Johnson Vision: Global vision-care leader spanning contact lenses (Acuvue) and lens care solutions; comparable to OMISAN's Visialens and EasyDay lens-care product lines.
• Rohto Pharmaceutical: Japanese global ophthalmic OTC player with preservative-free and hyaluronic-acid drops in many markets, comparable to OMISAN's preservative-free portfolio strategy.

Emerging players

• MediLogix (Medivis): Italian-based ophthalmic device and drop specialist focused on preservative-free and innovative delivery formats; partial overlap with OMISAN's preservative-free and micro-nebulizer technology positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCwLvVKjbvl6DeIAyMsf-IVg
• Facebookfacebook.com/Omisan-193228794033609
• LinkedInlinkedin.com/company/omisan

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omisan Farmaceutici